Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysis

Background: One potential treatment target for cancer cells is telomerase, an essential enzyme involved in the longevity of cancer cells. Current cancer treatments targeting telomerase often involve synthetic drugs with significant side effects, necessitating alternative approaches such as plant-bas...

Full description

Saved in:
Bibliographic Details
Main Authors: Rahil Ummar Faruk Abbu, Shaik Mohammad Abdul Fayaz, Divyashree M S, Raghu Chandrashekhar H, Prasanna Kumar Reddy Gayam, Archana Mahadev Rao
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Phytomedicine Plus
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667031324001805
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861175331323904
author Rahil Ummar Faruk Abbu
Shaik Mohammad Abdul Fayaz
Divyashree M S
Raghu Chandrashekhar H
Prasanna Kumar Reddy Gayam
Archana Mahadev Rao
author_facet Rahil Ummar Faruk Abbu
Shaik Mohammad Abdul Fayaz
Divyashree M S
Raghu Chandrashekhar H
Prasanna Kumar Reddy Gayam
Archana Mahadev Rao
author_sort Rahil Ummar Faruk Abbu
collection DOAJ
description Background: One potential treatment target for cancer cells is telomerase, an essential enzyme involved in the longevity of cancer cells. Current cancer treatments targeting telomerase often involve synthetic drugs with significant side effects, necessitating alternative approaches such as plant-based therapeutics. This study investigates the anti-telomerase activity of twelve phytochemicals derived from Blumea eriantha for cancer treatment. Methods: We examined the binding relationships between telomerase and the phytochemicals by performing molecular docking using Glide – Schrödinger, CB-Dock2 (Covalent Blind Docking 2), and Achilles Blind Docking. To further assess the interaction and stability of these phytochemicals and predict their behavior in a biological environment when targeting telomerase, we conducted molecular dynamic simulations using Desmond–Schrödinger. A comprehensive pharmacokinetic analysis using SwissADME and pkCSM (Pharmacokinetics and Toxicity by Computational Structure-based Models) supported these results by determining the drug-like qualities of these phytochemicals. The study further went on to identify synergistic treatment combinations using the Handy Recommendation Algorithm for Cancer Synergy (HRACS), where certain pairs of phytochemicals demonstrated enhanced anti-cancer efficacy against telomerase protein in A549 and MCF-7 cancer cell lines, suggesting that combinatorial therapy techniques may have potential. Results: Among the phytochemicals evaluated, Tyrphostin AG494 demonstrated the highest binding affinity to telomerase, as evidenced by its lowest interaction energy, with a Glide – Schrödinger Docking Score of -8.802 kcal/mol and a CB-Dock2 and Achilles Blind Docking Score of -8.5 kcal/mol. The phytochemical also exhibited a robust binding affinity mediated by consistent magnesium metal ion interactions involving key residues such as Asp251, Asp252, Ile252, and Asp343, along with additional hydrogen bonding and water-mediated contacts that enhance its stability and selectivity. Furthermore, all the phytochemicals, except Quassimarin, demonstrated various drug-like ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) parameters and validated Lipinski's rule of five, Veber, and Egan drug-likeness rules. Conclusion: Tyrphostin AG494 is the most effective natural phytochemical for inhibiting telomerase, exhibiting excellent binding affinity and stability, strong ADMET properties, and a safe toxicity profile. Therefore, following experimental validation, Tyrphostin AG494 is the most suitable and prospective candidate for telomerase inhibition and cancer therapy.
format Article
id doaj-art-49ed06a465a84bb69fe7b89d3c567e34
institution Kabale University
issn 2667-0313
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Phytomedicine Plus
spelling doaj-art-49ed06a465a84bb69fe7b89d3c567e342025-02-10T04:35:13ZengElsevierPhytomedicine Plus2667-03132025-02-0151100706Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysisRahil Ummar Faruk Abbu0Shaik Mohammad Abdul Fayaz1Divyashree M S2Raghu Chandrashekhar H3Prasanna Kumar Reddy Gayam4Archana Mahadev Rao5Department of Biotechnology, Manipal Institute of Technology (MIT), Manipal Academy of Higher Education (MAHE), Manipal, Karnataka 576104, IndiaDepartment of Biotechnology, Manipal Institute of Technology (MIT), Manipal Academy of Higher Education (MAHE), Manipal, Karnataka 576104, IndiaDepartment of Biotechnology, Manipal Institute of Technology (MIT), Manipal Academy of Higher Education (MAHE), Manipal, Karnataka 576104, IndiaDepartment of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences (MCOPS), Manipal Academy of Higher Education (MAHE), Manipal, Karnataka 576104, IndiaDepartment of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences (MCOPS), Manipal Academy of Higher Education (MAHE), Manipal, Karnataka 576104, IndiaDepartment of Biotechnology, Manipal Institute of Technology (MIT), Manipal Academy of Higher Education (MAHE), Manipal, Karnataka 576104, India; Corresponding author.Background: One potential treatment target for cancer cells is telomerase, an essential enzyme involved in the longevity of cancer cells. Current cancer treatments targeting telomerase often involve synthetic drugs with significant side effects, necessitating alternative approaches such as plant-based therapeutics. This study investigates the anti-telomerase activity of twelve phytochemicals derived from Blumea eriantha for cancer treatment. Methods: We examined the binding relationships between telomerase and the phytochemicals by performing molecular docking using Glide – Schrödinger, CB-Dock2 (Covalent Blind Docking 2), and Achilles Blind Docking. To further assess the interaction and stability of these phytochemicals and predict their behavior in a biological environment when targeting telomerase, we conducted molecular dynamic simulations using Desmond–Schrödinger. A comprehensive pharmacokinetic analysis using SwissADME and pkCSM (Pharmacokinetics and Toxicity by Computational Structure-based Models) supported these results by determining the drug-like qualities of these phytochemicals. The study further went on to identify synergistic treatment combinations using the Handy Recommendation Algorithm for Cancer Synergy (HRACS), where certain pairs of phytochemicals demonstrated enhanced anti-cancer efficacy against telomerase protein in A549 and MCF-7 cancer cell lines, suggesting that combinatorial therapy techniques may have potential. Results: Among the phytochemicals evaluated, Tyrphostin AG494 demonstrated the highest binding affinity to telomerase, as evidenced by its lowest interaction energy, with a Glide – Schrödinger Docking Score of -8.802 kcal/mol and a CB-Dock2 and Achilles Blind Docking Score of -8.5 kcal/mol. The phytochemical also exhibited a robust binding affinity mediated by consistent magnesium metal ion interactions involving key residues such as Asp251, Asp252, Ile252, and Asp343, along with additional hydrogen bonding and water-mediated contacts that enhance its stability and selectivity. Furthermore, all the phytochemicals, except Quassimarin, demonstrated various drug-like ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) parameters and validated Lipinski's rule of five, Veber, and Egan drug-likeness rules. Conclusion: Tyrphostin AG494 is the most effective natural phytochemical for inhibiting telomerase, exhibiting excellent binding affinity and stability, strong ADMET properties, and a safe toxicity profile. Therefore, following experimental validation, Tyrphostin AG494 is the most suitable and prospective candidate for telomerase inhibition and cancer therapy.http://www.sciencedirect.com/science/article/pii/S2667031324001805Molecular dockingPhytochemicalsPharmacokineticsTelomerase
spellingShingle Rahil Ummar Faruk Abbu
Shaik Mohammad Abdul Fayaz
Divyashree M S
Raghu Chandrashekhar H
Prasanna Kumar Reddy Gayam
Archana Mahadev Rao
Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysis
Phytomedicine Plus
Molecular docking
Phytochemicals
Pharmacokinetics
Telomerase
title Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysis
title_full Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysis
title_fullStr Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysis
title_full_unstemmed Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysis
title_short Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysis
title_sort telomerase inhibiting phytochemicals derived from blumea eriantha for cancer treatment a comprehensive computational analysis
topic Molecular docking
Phytochemicals
Pharmacokinetics
Telomerase
url http://www.sciencedirect.com/science/article/pii/S2667031324001805
work_keys_str_mv AT rahilummarfarukabbu telomeraseinhibitingphytochemicalsderivedfromblumeaerianthaforcancertreatmentacomprehensivecomputationalanalysis
AT shaikmohammadabdulfayaz telomeraseinhibitingphytochemicalsderivedfromblumeaerianthaforcancertreatmentacomprehensivecomputationalanalysis
AT divyashreems telomeraseinhibitingphytochemicalsderivedfromblumeaerianthaforcancertreatmentacomprehensivecomputationalanalysis
AT raghuchandrashekharh telomeraseinhibitingphytochemicalsderivedfromblumeaerianthaforcancertreatmentacomprehensivecomputationalanalysis
AT prasannakumarreddygayam telomeraseinhibitingphytochemicalsderivedfromblumeaerianthaforcancertreatmentacomprehensivecomputationalanalysis
AT archanamahadevrao telomeraseinhibitingphytochemicalsderivedfromblumeaerianthaforcancertreatmentacomprehensivecomputationalanalysis